Targeting Gut Serotonin Shows Promise for Safer Depression Treatments

New research highlights the potential of gut-specific antidepressants to improve mood disorders while minimizing systemic side effects, especially during pregnancy.

• Researchers found that increasing serotonin in the gut epithelium improved symptoms of anxiety and depression in animal models without causing digestive side effects.
• Current systemic antidepressants, such as SSRIs, may lead to gastrointestinal issues and other adverse effects, including functional constipation in children exposed during pregnancy.
• The study identified the gut-brain connection as a key pathway, with serotonin in the gut influencing mood via the vagus nerve's communication to the brain.
• Gut-targeted antidepressants could provide a safer alternative for treating mood disorders, particularly for pregnant women, by limiting drug transmission to the fetus.
• The findings call for further research into gut-specific treatments, though researchers caution against immediate changes to clinical practices for expectant mothers.

3 Articles

Neuroscience News GEN Technology Networks